Global Pre-Implantation Genetic Diagnosis (PGD) Market Size, Status and Forecast 2021-2027

Global Pre-Implantation Genetic Diagnosis (PGD) Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chromosomal Abnormalities
1.2.3 X-linked Diseases
1.2.4 Freeze Embryo Testing
1.2.5 Aneuploidy Screening
1.2.6 HLA
1.2.7 Others
1.3 Market by Application
1.3.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Stem Cell Therapy
1.3.3 IVF Prognosis
1.3.4 Late-Onset Genetic Disorders
1.3.5 Inherited Genetic Disease
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Perspective (2016-2027)
2.2 Pre-Implantation Genetic Diagnosis (PGD) Growth Trends by Regions
2.2.1 Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pre-Implantation Genetic Diagnosis (PGD) Historic Market Share by Regions (2016-2021)
2.2.3 Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Regions (2022-2027)
2.3 Pre-Implantation Genetic Diagnosis (PGD) Industry Dynamic
2.3.1 Pre-Implantation Genetic Diagnosis (PGD) Market Trends
2.3.2 Pre-Implantation Genetic Diagnosis (PGD) Market Drivers
2.3.3 Pre-Implantation Genetic Diagnosis (PGD) Market Challenges
2.3.4 Pre-Implantation Genetic Diagnosis (PGD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Revenue
3.1.1 Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Revenue (2016-2021)
3.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2016-2021)
3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pre-Implantation Genetic Diagnosis (PGD) Revenue
3.4 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio
3.4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2020
3.5 Pre-Implantation Genetic Diagnosis (PGD) Key Players Head office and Area Served
3.6 Key Players Pre-Implantation Genetic Diagnosis (PGD) Product Solution and Service
3.7 Date of Enter into Pre-Implantation Genetic Diagnosis (PGD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pre-Implantation Genetic Diagnosis (PGD) Breakdown Data by Type
4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Type (2016-2021)
4.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2022-2027)
5 Pre-Implantation Genetic Diagnosis (PGD) Breakdown Data by Application
5.1 Global Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Application (2016-2021)
5.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2016-2027)
6.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
6.2.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
6.2.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
6.2.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
6.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
6.3.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
6.3.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
6.3.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
6.4 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
6.4.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021)
6.4.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size (2016-2027)
7.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
7.2.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
7.2.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
7.2.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
7.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
7.3.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
7.3.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
7.3.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
7.4 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
7.4.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021)
7.4.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size (2016-2027)
8.2 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
8.2.1 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
8.3 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
8.3.1 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
8.4 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region
8.4.1 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2016-2027)
9.2 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
9.2.1 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
9.2.2 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
9.2.3 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
9.3 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
9.3.1 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
9.3.2 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
9.3.3 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
9.4 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
9.4.1 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021)
9.4.2 Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size (2016-2027)
10.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
10.2.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2027)
10.3 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
10.3.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2027)
10.4 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
10.4.1 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.1.4 Roche Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Genea Limited
11.2.1 Genea Limited Company Details
11.2.2 Genea Limited Business Overview
11.2.3 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.2.4 Genea Limited Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.2.5 Genea Limited Recent Development
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Details
11.3.2 Quest Diagnostics Business Overview
11.3.3 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.3.4 Quest Diagnostics Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.3.5 Quest Diagnostics Recent Development
11.4 Illumina, Inc.
11.4.1 Illumina, Inc. Company Details
11.4.2 Illumina, Inc. Business Overview
11.4.3 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.4.4 Illumina, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.4.5 Illumina, Inc. Recent Development
11.5 Natera, Inc.
11.5.1 Natera, Inc. Company Details
11.5.2 Natera, Inc. Business Overview
11.5.3 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.5.4 Natera, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.5.5 Natera, Inc. Recent Development
11.6 Cooper Medical, Inc.
11.6.1 Cooper Medical, Inc. Company Details
11.6.2 Cooper Medical, Inc. Business Overview
11.6.3 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.6.4 Cooper Medical, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.6.5 Cooper Medical, Inc. Recent Development
11.7 LabCorp
11.7.1 LabCorp Company Details
11.7.2 LabCorp Business Overview
11.7.3 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.7.4 LabCorp Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.7.5 LabCorp Recent Development
11.8 California Pacific Medical Center (CPMC)
11.8.1 California Pacific Medical Center (CPMC) Company Details
11.8.2 California Pacific Medical Center (CPMC) Business Overview
11.8.3 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.8.4 California Pacific Medical Center (CPMC) Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.8.5 California Pacific Medical Center (CPMC) Recent Development
11.9 Thermo Fisher Scientific Inc.
11.9.1 Thermo Fisher Scientific Inc. Company Details
11.9.2 Thermo Fisher Scientific Inc. Business Overview
11.9.3 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.9.4 Thermo Fisher Scientific Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.9.5 Thermo Fisher Scientific Inc. Recent Development
11.10 IGENOMIX
11.10.1 IGENOMIX Company Details
11.10.2 IGENOMIX Business Overview
11.10.3 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.10.4 IGENOMIX Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.10.5 IGENOMIX Recent Development
11.11 Reproductive Genetic Innovations
11.11.1 Reproductive Genetic Innovations Company Details
11.11.2 Reproductive Genetic Innovations Business Overview
11.11.3 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.11.4 Reproductive Genetic Innovations Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.11.5 Reproductive Genetic Innovations Recent Development
11.12 CombiMatrix
11.12.1 CombiMatrix Company Details
11.12.2 CombiMatrix Business Overview
11.12.3 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.12.4 CombiMatrix Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
11.12.5 CombiMatrix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chromosomal Abnormalities
Table 3. Key Players of X-linked Diseases
Table 4. Key Players of Freeze Embryo Testing
Table 5. Key Players of Aneuploidy Screening
Table 6. Key Players of HLA
Table 7. Key Players of Others
Table 8. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions (2016-2021)
Table 12. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions (2022-2027)
Table 14. Pre-Implantation Genetic Diagnosis (PGD) Market Trends
Table 15. Pre-Implantation Genetic Diagnosis (PGD) Market Drivers
Table 16. Pre-Implantation Genetic Diagnosis (PGD) Market Challenges
Table 17. Pre-Implantation Genetic Diagnosis (PGD) Market Restraints
Table 18. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Players (2016-2021)
Table 20. Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2020)
Table 21. Ranking of Global Top Pre-Implantation Genetic Diagnosis (PGD) Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Pre-Implantation Genetic Diagnosis (PGD) Product Solution and Service
Table 25. Date of Enter into Pre-Implantation Genetic Diagnosis (PGD) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2016-2021)
Table 29. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Application (2016-2021)
Table 33. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2022-2027) & (US$ Million)
Table 65. Roche Company Details
Table 66. Roche Business Overview
Table 67. Roche Pre-Implantation Genetic Diagnosis (PGD) Product
Table 68. Roche Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 69. Roche Recent Development
Table 70. Genea Limited Company Details
Table 71. Genea Limited Business Overview
Table 72. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product
Table 73. Genea Limited Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 74. Genea Limited Recent Development
Table 75. Quest Diagnostics Company Details
Table 76. Quest Diagnostics Business Overview
Table 77. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product
Table 78. Quest Diagnostics Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 79. Quest Diagnostics Recent Development
Table 80. Illumina, Inc. Company Details
Table 81. Illumina, Inc. Business Overview
Table 82. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
Table 83. Illumina, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 84. Illumina, Inc. Recent Development
Table 85. Natera, Inc. Company Details
Table 86. Natera, Inc. Business Overview
Table 87. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
Table 88. Natera, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 89. Natera, Inc. Recent Development
Table 90. Cooper Medical, Inc. Company Details
Table 91. Cooper Medical, Inc. Business Overview
Table 92. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
Table 93. Cooper Medical, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 94. Cooper Medical, Inc. Recent Development
Table 95. LabCorp Company Details
Table 96. LabCorp Business Overview
Table 97. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product
Table 98. LabCorp Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 99. LabCorp Recent Development
Table 100. California Pacific Medical Center (CPMC) Company Details
Table 101. California Pacific Medical Center (CPMC) Business Overview
Table 102. California Pacific Medical Center (CPMC) Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 103. California Pacific Medical Center (CPMC) Recent Development
Table 104. Thermo Fisher Scientific Inc. Company Details
Table 105. Thermo Fisher Scientific Inc. Business Overview
Table 106. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
Table 107. Thermo Fisher Scientific Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 108. Thermo Fisher Scientific Inc. Recent Development
Table 109. IGENOMIX Company Details
Table 110. IGENOMIX Business Overview
Table 111. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product
Table 112. IGENOMIX Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 113. IGENOMIX Recent Development
Table 114. Reproductive Genetic Innovations Company Details
Table 115. Reproductive Genetic Innovations Business Overview
Table 116. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product
Table 117. Reproductive Genetic Innovations Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 118. Reproductive Genetic Innovations Recent Development
Table 119. CombiMatrix Company Details
Table 120. CombiMatrix Business Overview
Table 121. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product
Table 122. CombiMatrix Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021) & (US$ Million)
Table 123. CombiMatrix Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type: 2020 VS 2027
Figure 2. Chromosomal Abnormalities Features
Figure 3. X-linked Diseases Features
Figure 4. Freeze Embryo Testing Features
Figure 5. Aneuploidy Screening Features
Figure 6. HLA Features
Figure 7. Others Features
Figure 8. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application: 2020 VS 2027
Figure 9. Stem Cell Therapy Case Studies
Figure 10. IVF Prognosis Case Studies
Figure 11. Late-Onset Genetic Disorders Case Studies
Figure 12. Inherited Genetic Disease Case Studies
Figure 13. Others Case Studies
Figure 14. Pre-Implantation Genetic Diagnosis (PGD) Report Years Considered
Figure 15. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions: 2020 VS 2027
Figure 18. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Regions (2022-2027)
Figure 19. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Players in 2020
Figure 20. Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2020
Figure 22. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2016-2021)
Figure 23. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2022-2027)
Figure 24. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 26. North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 27. North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2016-2027)
Figure 28. United States Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 32. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 33. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2016-2027)
Figure 34. Germany Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Pre-Implantation Genetic Diagnosis (PGD) Market Share by Region (2016-2027)
Figure 44. China Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 52. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 53. Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2016-2027)
Figure 54. Mexico Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2016-2027)
Figure 60. Turkey Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Roche Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 64. Genea Limited Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 65. Quest Diagnostics Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 66. Illumina, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 67. Natera, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2016-2021)
Figure 68. Cooper Medical, Inc. Revenue

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs